Incidence and risk of QTc interval prolongation among cancer patients treated with vandetanib: a systematic review and meta-analysis.

PloS One
Jiajie ZangJia He

Abstract

Vandetanib is a multikinase inhibitor that is under assessment for the treatment of various cancers. QTc interval prolongation is one of the major adverse effects of this drug, but the reported incidence varies substantially among clinical trials. We performed a systematic review and meta-analysis to obtain a better understanding in the risk of QTc interval prolongation among cancer patients administered vandetanib. Eligible studies were phase II and III prospective clinical trials that involved cancer patients who were prescribed vandetanib 300 mg/d and that included data on QTc interval prolongation. The overall incidence and risk of QTc interval prolongation were calculated using random-effects or fixed-effects models, depending on the heterogeneity of the included studies. Nine trials with 2,188 patients were included for the meta-analysis. The overall incidence of all-grade and high-grade QTc interval prolongation was 16.4% (95% CI, 8.1-30.4%) and 3.7% (8.1-30.4%), respectively, among non-thyroid cancer patients, and 18.0% (10.7-28.6%) and 12.0% (4.5-28.0%), respectively, among thyroid cancer patients. Patients with thyroid cancer who had longer treatment duration also had a higher incidence of high-grade events, with a re...Continue Reading

References

Jan 6, 1977·The New England Journal of Medicine·W F CrowleyF Maloof
Feb 1, 1996·Controlled Clinical Trials·A R JadadH J McQuay
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Jul 17, 2001·Clinical Endocrinology·R M ColzaniG Iervasi
Aug 8, 2001·British Journal of Clinical Pharmacology·M S GillenJ Morganroth
Apr 22, 2003·Progress in Cardiovascular Diseases·Sami ViskinDavid Zeltser
May 9, 2003·The New England Journal of Medicine·Silvia G PrioriDonata Cappelletti
Aug 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mary VarterasianDiane Healey
Sep 27, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean T BarbeySteven L Soignet
Jan 30, 2004·Recent Progress in Hormone Research·Serafino FazioBernadette Biondi
Oct 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Justin D FloydMichael C Perry
Aug 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elizabeth L StrevelLillian L Siu
Sep 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew M ArnoldUNKNOWN National Cancer Institute of Canada Clinical Trials Group Study BR.20
Apr 2, 2008·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Katsuyuki KiuraMasahiro Fukuoka
May 9, 2008·The Journal of Endocrinology·Charlotte van NoordBruno H Ch Stricker
Aug 8, 2008·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·O BakinerN G Demirag
Oct 22, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John V HeymachBruce E Johnson
Apr 1, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ronald B NataleMalcolm Ranson
Jan 13, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Samuel A WellsMartin Schlumberger
Feb 2, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard H de BoerJohan F Vansteenkiste
Feb 2, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ronald B NataleGlenwood D Goss
Mar 27, 2012·The Medical Clinics of North America·Sara Danzi, Irwin Klein

❮ Previous
Next ❯

Citations

Apr 27, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rashmi R ShahDevron R Shah
Jun 23, 2012·Clinical Medicine Insights. Oncology·Nils DegrauweHari A Deshpande
Nov 20, 2013·Advances in Therapy·Enrique GrandeJaume Capdevila
Dec 4, 2012·Current Opinion in Oncology·Michael J CampbellJessica Gosnell
Oct 17, 2014·Expert Opinion on Pharmacotherapy·Jolanta Krajewska, Barbara Jarzab
Jan 22, 2015·Expert Opinion on Pharmacotherapy·Jolanta KrajewskaBarbara Jarzab
Nov 5, 2015·Expert Review of Clinical Pharmacology·Jolanta KrajewskaBarbara Jarzab
Aug 5, 2014·Expert Opinion on Investigational Drugs·Antonella De LucaNicola Normanno
Feb 27, 2015·International Journal of Cancer. Journal International Du Cancer·Andreas K A GaumannGeorg Breier
Feb 24, 2016·Future Oncology·Srinath SundararajanNicholas J Vogelzang
Aug 5, 2015·Future Cardiology·Michael G Fradley, Javier Pinilla-Ibarz
May 24, 2015·Cardiac Electrophysiology Clinics·Michael G Fradley, Javid Moslehi
Jun 15, 2016·Expert Opinion on Drug Safety·Venessa H M TsangDiana L Learoyd
Sep 13, 2016·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Tatiana KelilSree Harsha Tirumani
Apr 12, 2017·Antioxidants & Redox Signaling·Carlo Gabriele TocchettiGiuseppe Mercuro
Nov 8, 2012·Clinical Medicine Insights. Oncology·H A DeshpandeS Roman
Aug 21, 2018·Expert Opinion on Therapeutic Targets·Jason TasoulasStamatios Theocharis
Aug 22, 2018·Expert Opinion on Drug Safety·Antonis A ManolisAntonis S Manolis
Mar 14, 2019·Current Opinion in Oncology·Venessa H M Tsang
Feb 11, 2020·Toxicological Sciences : an Official Journal of the Society of Toxicology·Jessica A PalmerRobert E Burrier
Jun 25, 2016·The Cancer Journal·Sheetal Mehta KircherAl B Benson
Jan 13, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Juan TamargoEva Delpón
Apr 25, 2016·Current Cardiology Reports·Federico ViganegoMichael G Fradley
Jun 2, 2017·Endocrinology, Diabetes & Metabolism Case Reports·Ayanthi A WijewardeneVenessa H M Tsang
Mar 23, 2018·Frontiers in Physiology·Gilda VarricchiCarlo G Tocchetti
Mar 1, 2017·Expert Review of Endocrinology & Metabolism·Jolanta KrajewskaBarbara Jarzab
Jan 7, 2021·Clinical Science·Stephen J H DobbinNinian N Lang
Feb 4, 2021·Disease Markers·Ștefan SpînuAndrei Cosmin Cismaru
Jan 5, 2021·JNCI Cancer Spectrum·Marina T Van LeeuwenClaire M Vajdic
Apr 7, 2021·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Neeraj Chhabra, Joseph Kennedy
Jul 4, 2021·The American Journal of Medicine·Hani EssaGregory Y H Lip

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
surgical resection

Software Mentioned

Comprehensive Meta Analysis
CTCAE

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.